Skip to Main Content

Author Details

David Clouston
1995
57
24
PMIDPaper TitleJournal TitlePublished Year
37100665Signet ring stromal tumours of testis: a tale of two cases on a morphological spectrum.Pathology2023
37208678Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.BMC Cancer2023
34687792Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.Cancer Lett2022
35764368Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.J Immunother Cancer2022
36270849LOT and HOT ⿦ or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.Pathology2022
35892882Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.Cancers (Basel)2022
35950036Cribriform pattern disease over-represented in pelvic lymph node metastases identified on <sup>68</sup>GA PSMA-PET/CT.BJUI Compass2022
34949766Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.Mod Pathol2022
34784097Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.BJU Int2022
34232604SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.Am J Surg Pathol2021
33620092Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer.J Pathol2021
34413304The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.Nat Commun2021
32132214Knowing what's growing: Why ductal and intraductal prostate cancer matter.Sci Transl Med2020
31843189Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.Pathology2020
30930118Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.Cancer Cell2019
31185217Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging.Cancer Cell2019
31212368Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.Prostate2019
31279442Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.Pathology2019
28977728Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.BJU Int2018
30049486Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.Eur Urol2018
29680797Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask.BMJ Case Rep2018
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29119638Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.Histopathology2018
28067867Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Nat Commun2017
28342640Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.Eur Urol2017
27014658Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years.Prostate Int2016
26534844Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.J Med Genet2016
26585945Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.Urol Oncol2016
27995114Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria.Prostate Int2016
27095381Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.Breast J2016
24784491Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort.BJU Int2015
25864171Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.Int J Radiat Oncol Biol Phys2015
25154392Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.Eur Urol2015
24192979Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.Eur Radiol2014
25263387Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.Ann Diagn Pathol2014
24053510Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens.BJU Int2014
24127673Metaplastic conditions of the bladder.BJU Int2013
22658218Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.Int J Radiat Oncol Biol Phys2012
23194119In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate.BJU Int2012
23035815High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.BJU Int2012
22458488In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.BJU Int2012
21733824Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.Cancer Prev Res (Phila)2011
22085120Penile lichen sclerosus (balanitis xerotica obliterans).BJU Int2011
21600669Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.Radiother Oncol2011
21716159Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.Pathology2011
19651608CT-X antigen expression in human breast cancer.Proc Natl Acad Sci U S A2009
17924939Transitional cell carcinoma in the paediatric population: be aware of unusual aetiologies.J Paediatr Child Health2007
11865070Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors.Mol Cell Biol2002
12121169Autoimmune pancreatitis.ANZ J Surg2002
10995745Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors.J Biol Chem2001
  • 1 - 50 of 57

Recommended Authors

University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 2
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 4
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 9
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 5
University of Toronto
Career Start Year 2006
Number of shared co-authors 8
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 7
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 6
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 10
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 11
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 12
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 11
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 10
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 21
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 10
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 5
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 5
University of Bern
Career Start Year 1990
Number of shared co-authors 22
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 6
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 4
University of Oxford
Career Start Year 1987
Number of shared co-authors 11
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
University of British Columbia
Career Start Year 1985
Number of shared co-authors 9
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 19
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 20
Queen's University
Career Start Year 1982
Number of shared co-authors 12
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 6
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 15

Collaborators

University of Melbourne
Co-authored papers 20
Peter MacCallum Cancer Centre
Co-authored papers 13
Biomedicine Discovery Institute, Monash University
Co-authored papers 12
Peter MacCallum Cancer Centre
Co-authored papers 12
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 10
Monash University
Co-authored papers 9
Biomedicine Discovery Institute, Monash University
Co-authored papers 9
Biomedicine Discovery Institute, Monash University
Co-authored papers 6
Karolinska Institute
Co-authored papers 5
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 4
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Co-authored papers 4
University Hospital Zurich
Co-authored papers 3
The Sir Peter MacCallum Department of Oncology University of Melbourne
Co-authored papers 3
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 3
University Health Network, University of Toronto
Co-authored papers 3
University of Toronto
Co-authored papers 3
University of Queensland
Co-authored papers 3
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Co-authored papers 2
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Co-authored papers 2
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Co-authored papers 2
McGill University Health Centre, McGill University
Co-authored papers 2
Peter MacCallum Cancer Centre
Co-authored papers 2
The University of Melbourne
Co-authored papers 2
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
University of Newcastle
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1